Lonza Group AG

Moderna and Lonza announced a 10-year strategic collaboration agreement to enable larger scale manufacture of Moderna's mRNA vaccine (mRNA-1273) against the novel coronavirus and additional Moderna products in the future.

Lonza is adding two new conjugation suites to its antibody-drug conjugate (ADC) facility in Visp, Switzerland, with new capacity expected online by Q3 2021.

Dosecann, a subsidiary of Auxly Cannabis Group, entered a definitive agreement with Capsugel (Lonza) to acquire a complete line of capsule filling and sealing equipment, including LEMS technology and Licaps capsules, for its PEI facility. The capacity is up to 200 million capsules per year.

Platinum Equity has completed the acquisition of Lonza's water care business in a transaction valued at approximately $630 million. The business, headquartered in Alpharetta, GA, has six production facilities across North America, South America, and EMEA.

Emerald Health Pharmaceuticals signed a contract with Lonza to manufacture its synthetic cannabinoid derivative VCE-004.8, including API in Nansha, China, hard capsules in Edinburgh, Scotland, and soft gels in Ploermel, France.

Platinum Equity has entered into a definitive agreement to acquire Lonza's Water Care business and operations for USD 630 million. The business has six manufacturing facilities and approximately 1,200 employees.

Lonza will invest $46 million to expand its Greenwood County, South Carolina operations, adding 50,000 square feet of manufacturing space and creating 30 new jobs. Construction is expected to be completed in Q2 2019.

Lonza will increase contract production of Portola Pharmaceuticals' AndexXa at its Visp, Switzerland plant, joining its Porrino, Spain facility.

Lonza completed the acquisition of Capsugel from KKR for USD 5.5 billion in cash, including refinancing of approximately USD 2 billion in existing Capsugel debt.

Azelis announced an extended distribution agreement to offer Lonza's Materials Protection ingredients (biocides) to coatings, inks, adhesives and sealants markets in Germany, Switzerland, UK, Benelux, Bulgaria, Slovenia, Croatia, Serbia and Ukraine, effective January 1, 2017.

Azelis announced an extended distribution agreement to offer Lonza's materials protection ingredients in Germany, Switzerland, UK, Benelux, Bulgaria, Slovenia, Croatia, Serbia and Ukraine, effective 1 January 2017.

Lonza Group AG agreed to acquire Capsugel S.A. from KKR for USD 5.5 billion in cash, including refinancing of existing Capsugel debt of approximately USD 2 billion.